MENU
XCUR
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Exicure (XCUR) Ownership - Who owns Exicure?
Exicure Inc is an early-stage biotechnology company focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets... Show more
Profile
Industry
N/A
Address
2430 N. Halsted Street
Phone
+1 847 673-1700
Employees
13
Web
https://www.exicuretx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
53.32M
P/E Ratio
0.19
Total Cash
12.51M
Projected Growth
N/A
Total Debt
5.94M
Revenue
500K
Risk (Beta)
5.87
Dividend Yield
N/A
Total Cash/Share
1.98
Total Debt/Equity
N/A
Revenue/Share
0.24 USD as % of share price
Fundamentals
XCUR
Capitalization
53.3M
P/E Ratio
0.19
Risk (Beta)
5.87
Dividend Yield
N/A
Total Cash
12.5M
Total Cash/Share
1.98
Total Debt
5.94M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.24%
Revenue
500K
ROE
N/A
Book Value
6.77M
P/B Ratio
7.87
Cash Flow
N/A
Earnings
-4.75
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
1K
Current Ratio
4.45
Current Revenue Per Employee
100000.00
Dividends Per Share - Security
N/A
EBITDA
-8.85M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-72.84
Shares Held By Institutions
4.29M
Shares Outstanding - Current
6.32M
Total Liabilities
8.28M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-38.259
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a company, which engages in the provision of clinical stage biotechnology company
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
2430 N. Halsted Street
Phone
+1 847 673-1700
Employees
13
Web
https://www.exicuretx.com